| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |